$136 Million is the total value of Samjo Capital LLC's 19 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 5.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PDFS | Buy | PDF SOLUTIONS INC | $32,256,000 | +29.0% | 1,400,000 | +1.8% | 23.68% | +40.0% |
ASPN | Sell | ASPEN AEROGELS INC | $16,104,000 | +49.1% | 350,000 | -3.0% | 11.82% | +61.7% |
VG | Sell | VONAGE HLDGS CORP | $12,251,000 | +11.1% | 760,000 | -0.7% | 9.00% | +20.5% |
QUOT | Sell | QUOTIENT TECHNOLOGY INC | $9,603,000 | -65.1% | 1,650,000 | -35.2% | 7.05% | -62.1% |
GTYH | Buy | GTY TECHNOLOGY HOLDINGS INC | $8,648,000 | +35.9% | 1,150,000 | +28.5% | 6.35% | +47.4% |
SCOR | Buy | COMSCORE INC | $8,015,000 | +13.7% | 2,055,000 | +45.7% | 5.88% | +23.3% |
ITI | Buy | ITERIS INC NEW | $7,524,000 | -12.3% | 1,425,000 | +10.5% | 5.52% | -4.9% |
REPH | Buy | RECRO PHARMA INC | $6,705,000 | +33.8% | 3,255,000 | +50.0% | 4.92% | +45.1% |
THRY | THRYV HLDGS INC | $5,798,000 | -16.0% | 193,000 | 0.0% | 4.26% | -8.9% | |
NEPH | Buy | NEPHROS INC | $4,824,000 | -14.3% | 550,000 | +0.2% | 3.54% | -7.1% |
GAN | GAN LTD | $4,387,000 | -9.5% | 295,000 | 0.0% | 3.22% | -1.9% | |
XGN | Buy | EXAGEN INC | $4,012,000 | +30.6% | 295,000 | +43.9% | 2.95% | +41.6% |
HTGM | Buy | HTG MOLECULAR DIAGNOSTICS IN | $3,769,000 | +21.5% | 660,000 | +23.6% | 2.77% | +31.8% |
INSE | Buy | INSPIRED ENTMT INC | $3,335,000 | +101.1% | 285,000 | +119.2% | 2.45% | +118.3% |
RSSS | Sell | RESEARCH SOLUTIONS INC | $2,346,000 | -25.4% | 900,000 | -18.2% | 1.72% | -19.1% |
FRG | FRANCHISE GROUP INC | $2,125,000 | +0.4% | 60,000 | 0.0% | 1.56% | +8.9% | |
ACCELERATE DIAGNOSTICS INCnote 2.500% 3/1 | $1,828,000 | +3.3% | 2,600,000 | 0.0% | 1.34% | +12.0% | ||
TACT | TRANSACT TECHNOLOGIES INC | $1,807,000 | +1.2% | 130,000 | 0.0% | 1.33% | +9.9% | |
DMRC | Sell | DIGIMARC CORP NEW | $861,000 | -56.4% | 25,000 | -57.6% | 0.63% | -52.8% |
INOV | Exit | INOVALON HLDGS INC | $0 | – | -305,000 | -100.0% | -7.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PDF SOLUTIONS INC | 12 | Q3 2023 | 30.2% |
THRYV HLDGS INC | 12 | Q3 2023 | 15.9% |
ASPEN AEROGELS INC | 12 | Q3 2023 | 11.8% |
ITERIS INC NEW | 12 | Q3 2023 | 14.0% |
DIGIMARC CORP NEW | 12 | Q3 2023 | 1.3% |
SOCIETAL CDMO INC | 11 | Q3 2023 | 6.4% |
COMSCORE INC | 11 | Q3 2023 | 6.3% |
QUOTIENT TECHNOLOGY INC | 10 | Q2 2023 | 29.1% |
INSPIRED ENTMT INC | 10 | Q3 2023 | 11.0% |
FRANCHISE GROUP INC | 10 | Q1 2023 | 4.0% |
View Samjo Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HTG MOLECULAR DIAGNOSTICS, INCSold out | February 10, 2023 | 0 | 0.0% |
ITERIS, INC. | February 10, 2023 | 3,280,000 | 7.7% |
Societal CDMO, Inc. | February 10, 2023 | 4,050,000 | 4.8% |
NEPHROS INC | February 08, 2022 | 425,000 | 4.2% |
Research Solutions, Inc. | February 08, 2022 | 1,280,000 | 4.8% |
HTG MOLECULAR DIAGNOSTICS, INC | February 11, 2021 | 381,713 | 8.1% |
NEPHROS INC | October 21, 2020 | 550,000 | 5.6% |
ARI NETWORK SERVICES INC /WI | February 10, 2017 | 941,800 | 5.4% |
Digimarc CORP | February 12, 2016 | 380,200 | 4.3% |
PRGX GLOBAL, INC. | February 09, 2015 | 1,175,000 | 4.3% |
View Samjo Capital LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-NT | 2024-02-09 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-10 |
SC 13G/A | 2023-02-10 |
SC 13G/A | 2023-02-10 |
SC 13G/A | 2023-02-10 |
13F-HR | 2023-02-08 |
13F-HR | 2022-11-07 |
13F-HR | 2022-08-04 |
View Samjo Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.